Burrage Capital

Burrage Capital Management was a specialized long-short equity hedge fund, investing primarily in biotechnology and medical technology sectors. The firm identified opportunities in companies developing drugs, medical devices, research tools, and diagnostic systems. Its analytical approach leveraged deep healthcare domain expertise to navigate complex market dynamics.

Founded in 2010 by Christiana Bardon, Burrage Capital Management stemmed from an insight into healthcare's unique investment potential. Bardon, with her medical background and extensive investment management experience, recognized the need for a fund equipped for rigorous due diligence on science-driven companies, enabling precise value identification within the sector.

The fund served institutional and sophisticated investors seeking exposure to high-growth healthcare markets. Burrage Capital's vision focused on generating superior returns through its specialized understanding of healthcare innovation. The firm aimed to capitalize on advancements reshaping medicine and patient care, aligning investment strategies with long-term industry trends.